Results 191 to 200 of about 2,312,469 (251)
Some of the next articles are maybe not open access.

Related searches:

Intermediate Uveitis: A Review

Ocular Immunology and Inflammation, 2022
This review aims to provide an update on the clinical presentation, etiologies, complications, and treatment options in intermediate uveitis (IU).Narrative literature review.IU affects all age groups with no clear gender predominance and has varied etiologies including systemic illnesses and infectious diseases, or pars planitis.
Andrea York Tiang Teo   +5 more
openaire   +3 more sources

Intermediate Uveitis

Seminars in Ophthalmology, 2005
Intermediate uveitis is an intraocular inflammation involving the anterior vitreous, peripheral retina and pars plana. It usually affects patients from 5 to 30 years old, without gender or racial preferences. The etiology is unknown but there are several associated diseases: multiple sclerosis, idiopathic optic neuritis, autoimmune corneal ...
Francisco Max Damico, Fernando Oréfice
exaly   +3 more sources

Pattern of Intermediate Uveitis in an Egyptian Cohort

Ocular Immunology and Inflammation, 2020
Purpose: To describe the clinical experience with intermediate uveitis at six Egyptian tertiary eye centers. Methods: A multicenter retrospective chart review of all patients with intermediate uveitis seen at six ocular inflammation referral clinics in ...
Ahmed Shawkat Abdelhalim   +1 more
exaly   +2 more sources

Ocular Complications of Intermediate Uveitis

Ocular Immunology and Inflammation
Intermediate uveitis (IU) in an intraocular inflammation that predominantly affects the vitreous. It typically manifests as chronic low-grade inflammation, mainly affecting children and young adults. Uncontrolled chronic intraocular inflammation carries a high risk of visual loss.
Radgonde, Amer, Yael, Sharon
openaire   +3 more sources

TREATMENT OF INTERMEDIATE UVEITIS-ASSOCIATED RETINAL VASOPROLIFERATIVE TUMORS: A CASE SERIES

Retinal cases & brief reports, 2023
The authors report a series of four patients with intermediate uveitis-associated retinal vasoproliferative tumors that were treated with a combination of intravitreal aflibercept, dexamethasone, and fluocinolone acetonide implants.
Ayman G. Elnahry   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy